{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:00:53Z","timestamp":1792098053406,"version":"4.4.0"},"reference-count":32,"publisher":"Swets & Zeitlinger Publishers","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1076\/ocii.8.4.293.6453","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T15:14:16Z","timestamp":1047309256000},"page":"293-301","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Beh\u00e7et's disease"],"prefix":"10.1076","volume":"8","author":[{"given":"Bertrand","family":"Wechsler","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Bodaghi","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L\u00ea","family":"Thi Huong","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fardeau","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Cassoux","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Piette","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc","family":"LeHoang","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hopital Pitie-Salpetriere, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"191","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1078","article-title":"'s disease","volume":"335","author":"Criteria for diagnosis of Behcet","year":"1990","unstructured":"Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 1990;335: 1078\u20131080.","journal-title":"International Study Group for Behcet's Disease. Lancet"},{"key":"e_1_2_1_3_1","unstructured":"Dinning W. An overview of ocular manifestations. In: Lehner T Barnes C editors. Recent Advances in Beh\ufffdet\ufffds Disease. London: Royal Society of Medicine Service 1986;227\u2013233."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(99)00029-5"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(95)31022-6"},{"key":"e_1_2_1_6_1","first-page":"701","article-title":"Dundar S","volume":"104","author":"Demiroglu H","year":"1997","unstructured":"Demiroglu H, Barista I, Dundar S. Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. Ophthalmology 1997;104:701\u2013705.","journal-title":"Risk factor assessment and prognosis of eye involvement in Behcet's disease in Turkey. Ophthalmology"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72840-5"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1998.760118.x"},{"key":"e_1_2_1_9_1","first-page":"409","article-title":"Schwab IR","volume":"125","author":"Reed JB","year":"1998","unstructured":"Reed JB, Morse LS, Schwab IR. High-dose intravenous pulse methylpred-nisolone hemisuccinate in acute Behcet retinitis. Am J Ophthalmol 1998;125:409\u2013411.","journal-title":"High-dose intravenous pulse methylpred-nisolone hemisuccinate in acute Behcet retinitis. Am J Ophthalmol"},{"key":"e_1_2_1_10_1","first-page":"723","article-title":"Dua HS","volume":"106","author":"Sloper CM","year":"1999","unstructured":"Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 1999; 106:723\u2013728.","journal-title":"Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000310490"},{"key":"e_1_2_1_12_1","first-page":"783","article-title":"Graham EM","volume":"12","author":"Greenwood AJ","year":"1998","unstructured":"Greenwood AJ, Stanford MR, Graham EM. The role of azathioprine in the management of retinal vasculitis. Eye 1998;12:783\u2013788.","journal-title":"The role of azathioprine in the management of retinal vasculitis. Eye"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400425"},{"key":"e_1_2_1_14_1","first-page":"343","article-title":"al","volume":"15","author":"Cochereau-Massin I","year":"1992","unstructured":"Cochereau-Massin I, Wechsler B, Le Hoang P, et al. Ocular prognosis in Behcet's disease. J Fr Ophtalmol 1992;15:343\u2013347.","journal-title":"Ocular prognosis in Behcet's disease. J Fr Ophtalmol"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360721"},{"key":"e_1_2_1_16_1","first-page":"335","volume":"278","author":"Tsambaos D","year":"1986","unstructured":"Tsambaos D, Eichelberg D, Goos M. Behcet's syndrome: treatment with recombinant leukocyte alpha-interferon. Arch Dermatol Res 1986; 278:335\u2013336.","journal-title":"Goos M. Behcet's syndrome: treatment with recombinant leukocyte alpha-interferon. Arch Dermatol Res"},{"key":"e_1_2_1_17_1","first-page":"720","article-title":"al","volume":"75","author":"Pivetti-Pezzi P","year":"1997","unstructured":"Pivetti-Pezzi P, Accorinti M, Pirraglia MP, et al. Interferon alpha for ocular Behcet's disease. Acta Ophthalmol Scand 1997;75:720\u2013722.","journal-title":"Interferon alpha for ocular Behcet's disease. Acta Ophthalmol Scand"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.5.488"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199901000-00007"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00159.x"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246374"},{"key":"e_1_2_1_22_1","unstructured":"Hamuryudan V Moral F Yurdakul S et al. Systemic interferon alpha 2h treatment in Behcet's syndrome. J Rheumatol 1994;21:1098-110o."},{"key":"e_1_2_1_23_1","first-page":"1938","article-title":"Interferon-alpha treatment of Behcet's disease","volume":"25","author":"O'Duffy JD","year":"1998","unstructured":"O'Duffy JD, Calamia K, Cohen S, et al. Interferon-alpha treatment of Behcet's disease. J Rheumatol 1998; 25:1938\u20131944.","journal-title":"J Rheumatol"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.8.1010"},{"key":"e_1_2_1_25_1","unstructured":"Pesce A Chichmanian R Vinti H et al. Interferon alpha2 and ocular toxicity. Rev Med Interne Suppl 1995; 16:5o1S."},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80331-9"},{"key":"e_1_2_1_27_1","first-page":"914","article-title":"Isogai Y","volume":"343","author":"Yamada H","year":"1994","unstructured":"Yamada H, Mizobuchi K, Isogai Y. Acute onset of ocular complications Acute onset of ocular complications with interferon [letter]. Lancet 1994; 343:914.","journal-title":"Acute onset of ocular complications Acute onset of ocular complications with interferon [letter]. Lancet"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.2.150"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1999.59"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(99)00021-X"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80131-7"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.1998.00127.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002960050091"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1076\/ocii.8.4.293.6453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T19:34:43Z","timestamp":1728934483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1076\/ocii.8.4.293.6453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1076\/ocii.8.4.293.6453"],"URL":"https:\/\/doi.org\/10.1076\/ocii.8.4.293.6453","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}